Cargando…

In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values

BACKGROUND: At present, the clinical breakpoints (CBPs) of both fluconazole and voriconazole are available only for 3 common Candida species in the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) methods. Epidemiological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Min Joong, Shin, Jong Hee, Lee, Wee Gyo, Kim, Mi-Na, Lee, Kyungwon, Lee, Hye Soo, Lee, Mi-Kyung, Chang, Chulhun L., Jang, Hee-Chang, Song, Eun Song, Kim, Soo Hyun, Shin, Myung-Geun, Suh, Soon-Pal, Ryang, Dong-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646190/ https://www.ncbi.nlm.nih.gov/pubmed/23667842 http://dx.doi.org/10.3343/alm.2013.33.3.167

Ejemplares similares

Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea
por: Jung, Sook-In, et al.
Publicado: (2012)

Species Distribution and Susceptibility to Azole Antifungals of Candida Bloodstream Isolates from Eight University Hospitals in Korea
por: Lee, Jin-Sol, et al.
Publicado: (2007)

Molecular and Clinical Features of Fluconazole Non-susceptible Candida albicans Bloodstream Isolates Recovered in Korean Multicenter Surveillance Studies
por: Choi, Min Ji, et al.
Publicado: (2023)

Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008–2018
por: Won, Eun Jeong, et al.
Publicado: (2021)

Time to switch from CLSI to EUCAST? A Southeast Asian perspective
por: Cusack, T.P., et al.
Publicado: (2019)

Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
por: Cusack, T.P., et al.
Publicado: (2019)

Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints
por: Sachu, Arun
Publicado: (2023)

Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines
por: Dabas, Yubhisha, et al.
Publicado: (2017)

Change of Antibiotic Susceptibility Testing Guidelines from CLSI to EUCAST: Influence on Cumulative Hospital Antibiograms
por: Wolfensberger, Aline, et al.
Publicado: (2013)

1269. Differences in Interpretative Breakpoints Between CLSI, FDA and EUCAST Impact Reporting of Susceptibility and Resistance to Cefiderocol
por: Yamano, Yoshinori, et al.
Publicado: (2020)

Multilocus Sequence Typing (MLST) Genotypes of Candida glabrata Bloodstream Isolates in Korea: Association With Antifungal Resistance, Mutations in Mismatch Repair Gene (Msh2), and Clinical Outcomes
por: Byun, Seung A., et al.
Publicado: (2018)

Prevalence of susceptibility patterns of opportunistic bacteria in line with CLSI or EUCAST among Haemophilus parainfluenzae isolated from respiratory microbiota
por: Kosikowska, Urszula, et al.
Publicado: (2020)

Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea
por: Choi, Yong Jun, et al.
Publicado: (2018)

Antifungal Susceptibilities of Bloodstream Isolates of Candida Species from Nine Hospitals in Korea: Application of New Antifungal Breakpoints and Relationship to Antifungal Usage
por: Won, Eun Jeong, et al.
Publicado: (2015)

Crossing Frequency Method Applicable to Intermediate Pressure Plasma Diagnostics Using the Cutoff Probe
por: Kim, Si-jun, et al.
Publicado: (2022)

Haemophilus influenzae blood-stream infection and third-generation cephalosporin susceptibility testing: a comparative case study using EUCAST and CLSI guidelines
por: Merlino, John, et al.
Publicado: (2023)

Optimal Waist Circumference Cutoff Values for Metabolic Syndrome Diagnostic Criteria in a Korean Rural Population
por: Koh, Jang Hyun, et al.
Publicado: (2010)

Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates
por: Buil, Jochem B., et al.
Publicado: (2018)

Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections
por: Kim, Yong Chan, et al.
Publicado: (2023)

Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement
por: Gaur, Priyanka, et al.
Publicado: (2023)

Catheter-related Bloodstream Infection due to Lodderomyces elongisporus in a Patient with Lung Cancer
por: Lee, Hye-Young, et al.
Publicado: (2018)

CLSI announces availability of new CLSI microbiology documents
Publicado: (2007)

1597. Evaluation of Ceftaroline Resistance (CPT-R) in Chile Across Time and a Comparison of CLSI vs. EUCAST Breakpoints in Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Khan, Ayesha, et al.
Publicado: (2019)

In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies
por: Rivero-Menendez, Olga, et al.
Publicado: (2021)

Comparison of an Automated Repetitive Sequence-based PCR Microbial Typing System with IS6110-Restriction Fragment Length Polymorphism for Epidemiologic Investigation of Clinical Mycobacterium tuberculosis Isolates in Korea
por: Jang, Mi Hee, et al.
Publicado: (2011)

Early Detection of Mycobacteria Using a Novel Hydrogel Culture Method
por: Jang, Mi Hee, et al.
Publicado: (2014)

Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole
por: Park, Dae Won, et al.
Publicado: (2006)

Disk Diffusion Susceptibility Testing for the Rapid Detection of Fluconazole Resistance in Candida Isolates
por: Jeon, Suhak, et al.
Publicado: (2021)

Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats
por: Lou, Yutao, et al.
Publicado: (2023)

Topical and Oral Voriconazole in the Treatment of Fungal Keratitis
por: Lee, Sang Joon, et al.
Publicado: (2009)

A Case of Pseudomembranous Colitis after Voriconazole Therapy
por: Kwon, Jae-Cheol, et al.
Publicado: (2011)

Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
por: Kim, Jihye, et al.
Publicado: (2018)

Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades
por: Jung, Sook-In, et al.
Publicado: (2016)

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates
por: Pfaller, Michael A., et al.
Publicado: (2016)

IS6110-Restriction Fragment Length Polymorphism and Spoligotyping Analysis of Mycobacterium tuberculosis Clinical Isolates for Investigating Epidemiologic Distribution in Korea
por: Choi, Go Eun, et al.
Publicado: (2010)

Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
por: Golestannejad, Zahra, et al.
Publicado: (2022)

Instruction videos from EUCAST
Publicado: (2020)

Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates
por: Chung, Hae-Sun, et al.
Publicado: (2013)

Extended Red Blood Cell Genotyping to Investigate Immunohematology Problems
por: Shin, Kyung-Hwa, et al.
Publicado: (2018)

Evaluation of fluconazole, itraconazole, and voriconazole activity on Candida albicans: A case control study
por: Partha, Agung Dewi Sekar Langit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1m19989j9fj0kn71kkoml13351